Patents Assigned to Orthopeutics, L.P.
  • Patent number: 10980771
    Abstract: A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: April 20, 2021
    Assignee: Orthopeutics, L.P.
    Inventors: Pawel Slusarewicz, David A. Puleo, Thomas Paul Hedman, Sharath C. Sundararaj
  • Patent number: 10278947
    Abstract: A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: May 7, 2019
    Assignee: ORTHOPEUTICS, L.P.
    Inventors: Pawel Slusarewicz, David A. Puleo, Thomas Paul Hedman, Sharath C. Sundararaj
  • Patent number: 9918870
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: March 20, 2018
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9492592
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: November 15, 2016
    Assignee: Orthopeutics, L. P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9192507
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: November 24, 2015
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9101602
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: August 11, 2015
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20150217025
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Application
    Filed: April 13, 2015
    Publication date: August 6, 2015
    Applicant: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 9084772
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: July 21, 2015
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20140161844
    Abstract: A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body can contain the protein crosslinker holding biodegradable polymer. The release rate of the crosslinker and total amount of crosslinker released can be controlled by varying the concentration of the crosslinker and by varying the composition and structural characteristics of the degradable polymer. Surface eroding, bulk eroding and naturally occurring biodegradable polymers can be used in conjunction with a variety of nontoxic or minimally-toxic protein crosslinking agents. The devices can be used to treat mechanically damaged, deformed, and nutritionally deficient connective or soft tissues such as the knee meniscus, the spinal disc, the cornea, ligaments and tendons, the soft palate, and skin.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 12, 2014
    Applicant: Orthopeutics, L.P.
    Inventors: Pawel Slusarewicz, David A. Puleo, Thomas Paul Hedman, Sharath C. Sundararaj
  • Patent number: 8450276
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: May 28, 2013
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20130087155
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Application
    Filed: June 28, 2011
    Publication date: April 11, 2013
    Applicant: ORTHOPEUTICS, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20130085569
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Application
    Filed: May 26, 2011
    Publication date: April 4, 2013
    Applicant: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8211938
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: July 3, 2012
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8153600
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic and other progressively deforming spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the elasticity and bending stiffness of progressively deforming spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the potential or progressing deformity curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: April 10, 2012
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8119599
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: February 21, 2012
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8022101
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: September 20, 2011
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman